5-Aryl thiazolidine-2,4-diones: discovery of PPAR dual α/γ agonists as antidiabetic agents-Reference-Cited by-同舟云学术

5-Aryl thiazolidine-2,4-diones: discovery of PPAR dual α/γ agonists as antidiabetic agents

Published:2003-08 Issue:16 Volume:13 Page:2795-2798
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Desai Ranjit C.,Han Wei,Metzger Edward J.,Bergman Jeffrey P.,Gratale Dominick F.,MacNaul Karen L.,Berger Joel P.,Doebber Thomas W.,Leung Kwan,Moller David E.,Heck James V.,Sahoo Soumya P.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference19 articles.

1. New therapies in diabetes – thiazolidinediones

2. Self-Rated Health and Diabetes of Long Duration: The Wisconsin Epidemiologic Study of Diabetic Retinopathy

3. Sulphonylurea Antidiabetic Drugs

4. Comparison of efficacy, secondary failure rate, and complications of sulfonylureas

5. Studies on antidiabetic agents. I. Synthesis of 5-(4-(2-methyl-2-phenylpropoxy)-benzyl)thiazolidine-2,4-dione (AL-321) and related compounds.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring fingerprints for antidiabetic therapeutics related to peroxisome proliferator-activated receptor gamma (PPARγ) modulators: A chemometric modeling approach;Computational Biology and Chemistry;2024-10

2. Chemistry and Applications of Functionalized 2,4‐Thiazolidinediones;European Journal of Organic Chemistry;2023-05-03

3. SYNTHESIS AND ANTICANCER ACTIVITY OF N-SUBSTITUTED INDOLE DERIVATIVES;INDIAN DRUGS;2022-02-21

4. Structural Perspectives and Advancement of SGLT2 Inhibitors for the Treatment of Type 2 Diabetes;Current Diabetes Reviews;2021-09-17

5. Lead Optimization Resources in Drug Discovery for Diabetes;Endocrine, Metabolic & Immune Disorders - Drug Targets;2019-09-03